Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

Ani Pharmaceuticals (ANIP) Shares Outstanding (2016 - 2022)

Historic Shares Outstanding for Ani Pharmaceuticals (ANIP) over the last 12 years, with Q2 2022 value amounting to $17.6 million.

  • Ani Pharmaceuticals' Shares Outstanding rose 3695.62% to $17.6 million in Q2 2022 from the same period last year, while for Jun 2022 it was $17.6 million, marking a year-over-year increase of 3695.62%. This contributed to the annual value of $16.9 million for FY2021, which is 3606.6% up from last year.
  • According to the latest figures from Q2 2022, Ani Pharmaceuticals' Shares Outstanding is $17.6 million, which was up 3695.62% from $17.4 million recorded in Q1 2022.
  • Ani Pharmaceuticals' 5-year Shares Outstanding high stood at $17.6 million for Q2 2022, and its period low was $11730.0 during Q1 2018.
  • Over the past 5 years, Ani Pharmaceuticals' median Shares Outstanding value was $12.2 million (recorded in 2020), while the average stood at $11.1 million.
  • Per our database at Business Quant, Ani Pharmaceuticals' Shares Outstanding soared by 10240639.39% in 2019 and then skyrocketed by 73.19% in 2020.
  • Quarter analysis of 5 years shows Ani Pharmaceuticals' Shares Outstanding stood at $11.9 million in 2018, then grew by 2.04% to $12.1 million in 2019, then grew by 2.68% to $12.4 million in 2020, then surged by 36.07% to $16.9 million in 2021, then grew by 3.86% to $17.6 million in 2022.
  • Its last three reported values are $17.6 million in Q2 2022, $17.4 million for Q1 2022, and $16.9 million during Q4 2021.